Semnur Pharms (SMNR) Stock Price, News & Analysis
What Changed
- With $35.3M in liabilities, Semnur (SMNR) depends on its parent for funding.
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
Price Move History
- Daily moves over 5%
- 78 125 sessions, November 10, 2025 to November 5, 2026
- Largest daily move
- -70% close of June 16, 2026
- 1-month change
- -33.3% closing prices, October 5, 2026 to November 5, 2026
Company Description
Semnur Pharms (OTC: SMNR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $69.1M.
SMNR has declined 33.3% over the past month. The last closing price was $0.3000.
For FY2025, Semnur Pharms reported diluted earnings per share of -$0.78.
This page collects what Stock Titan holds for SMNR, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Semnur Pharms (SMNR) closed at $0.3000 on November 5, 2026. Over the past month, the price has lost 33.3%.
SMNR Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Semnur Pharms has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all SMNR news →
SEC Filings
Semnur Pharms has filed 10 recent SEC filings, including 3 Form 10-Q, 2 Form 424B3, 2 Form 8-K, 1 Form 4. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
Semnur Pharms reported diluted earnings per share of -$0.78 in FY2025. The company generated -$5.9M in operating cash flow. The current ratio was 0.06, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Semnur Pharms (SMNR) currently stands at 83.5 thousand shares, down 5.8% from the previous reporting period, representing 0.2% of the float. Since November 2025, short interest has increased by 5035.6%.
Days to Cover History
Days to cover for Semnur Pharms (SMNR) currently stands at 10.2 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 63.1%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
SMNR Company Profile & Sector Positioning
Semnur Pharms (SMNR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SMNR often look at related companies in the same sector, including BetterLife Pharma Inc (BETRF), Vaxart Inc (VXRT), Starpharma Holdings (SPHRY), ProText Mobility Inc (TXTM), and Nuo Therapeutics Inc New (AURX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SMNR's relative position within its industry.